TITLE

New rules for opioid prescribing

AUTHOR(S)
Elliott, William T.
PUB. DATE
April 2009
SOURCE
Travel Medicine Advisor;Apr2009 Pharmacology Watch, p2
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article reports on the plans of the U.S. Food and Drug Administration to tightened regulations on use of opioid drugs in 2009. Such drugs include fentanyl, hydromorphone and oxymorphone, among others. The move is reportedly in reaction to the misuse and abuse of these drugs as of February 2009. Also noted are the clinical guidelines released by the American Academy of Pain Medicine Opioids Guidelines Panel for the use of chronic opioid therapy and chronic non-cancer pain.
ACCESSION #
37198928

 

Related Articles

  • Prevention of Fatal Opioid Overdose. Beletsky, Leo; Rich, Josiah D.; Walley, Alexander Y. // JAMA: Journal of the American Medical Association;11/14/2012, Vol. 308 Issue 18, p1863 

    In this article, the author discusses ways to prevent the over dosage of fatal opioid incidents in the U.S. He mentions that nearly 16,000 deaths occur annually in the country, due to opioid overdose. He stresses that the U.S. Food and Drug Administration (FDA) must keep a check on adequate...

  • FDA Panel Wants Stronger REMS for Opioids.  // BioWorld Today;7/26/2010, Vol. 21 Issue 142, p5 

    The article reports on the decision of a U.S. Food and Drug Administration (FDA) advisory panel to reject a classwide risk evaluation and mitigation strategy (REMS) plan proposed by the agency for extended-release and long-acting opioids. According to the panel, the plan was too weak to prevent...

  • FDA panels vote against plan to reduce opioid abuse.  // Medical Economics;8/20/2010, Vol. 87 Issue 16, p49 

    The article reports on the decision of two U.S. Food and Drug Administration (FDA) advisory panels to vote against a plan that would reduce abuse of long-acting and extended-release opioid drugs.

  • FDA APPROVES OPIOID OVERDOSE TREATMENT. Harrison, Sheena // Business Insurance;4/14/2014, Vol. 48 Issue 8, p0038 

    The article reports on the U.S. Food and Drug Administration approval given to Evzio, a prescription treatment that patients' family members or caregivers can use to treat opioid overdoses.

  • FDA finalizes opioid guidance. Weinstein, Deborah // Medical Marketing & Media;May2015, Vol. 50 Issue 5, p12 

    The article presents views of Douglas Throckmorton, deputy director of the regulatory programs at the U.S. Food and Drug Administration (FDA), on the guidance issued by FDA for the evaluation of abuse-deterrent opioid.

  • New rules for opioid prescribing. Elliott, William T. // Infectious Disease Alert;Apr2009 Pharmacology, p2 

    The article reports on the plans of the U.S. Food and Drug Administration (FDA) to issue new restrictions for opioid prescribing in 2009. Under the rules, opioid makers will be required to have a Risk Evaluation and Mitigation Strategy. Opioids included in the rules include fentanyl,...

  • Opioid Regulation Challenges FDA and Manufacturers. Wechsler, Jill // BioPharm International;Dec2013, Vol. 26 Issue 12, p12 

    The article focuses on the challenges faced by the U.S. Food and Drug Administration (FDA) and manufacturers over the regulation on opioids. The increase in misuse of long-acting opioids has led to efforts to formulate safer therapies for patients suffering from pain while also taking steps to...

  • FDA panel debates merits of next-generation opioid formulations. Lavine, Greg // American Journal of Health-System Pharmacy;1/1/2009, Vol. 66 Issue 1, p8 

    The article reports that there are abuse-resistant opioid drug products, which were examined by an advisory panel of Food and Drug Administration (FDA) on November 13 to 14, 2008. It notes that Remoxy XRT and Embeda aimed to deter abusers from tampering with the extended-release properties for...

  • Alkermes Aims Higher with New Vivitrol Indication.  // Bioworld Week;10/18/2010, Vol. 18 Issue 42, p1 

    The article reports on the U.S. Food and Drug Administration approval of the Alkermes Inc.'s Vivitrol non-addictive, non-narcotic treatment drug for alcohol opioid dependence. It states that the drug has been approved for the relapse prevention to opioid dependence and the October 12, 2010...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics